Zydus Lifesciences Shares Gain Marginally Over USFDA Approval forΒ DiabeticΒ Drug
Zydus Lifesciences shares were trading marginally above on 23 October after the company announced receiving approval from USFDA (the United States Food and Drug Administration)...